Jeffrey Settleman

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Lisa Choy, Stephen R Norris, Xiumin Wu, Ganesh Kolumam, Ari J Firestone, Jeffrey Settleman, David Stokoe
Inhibition of Aurora Kinase Induces Endogenous Retroelements to Induce a Type I/III IFN Response via RIG-I. Cancer research communications 4 (2) (2024)
Lisa Choy, Stephen R Norris, Xiumin Wu, Ganesh Kolumam, Ari J Firestone, Jeffrey Settleman, David Stokoe
Inhibition of Aurora Kinase Induces Endogenous Retroelements to Induce a Type I/III IFN Response via RIG-I. Cancer research communications 4 (2) (2024)
Lisa Choy, Stephen R Norris, Xiumin Wu, Ganesh Kolumam, Ari J Firestone, Jeffrey Settleman, David Stokoe
Inhibition of Aurora kinase induces endogenous retroelements to induce a type I/III interferon response via RIG-I. Cancer research communications (2024)
Matthew F Pech, Linda E Fong, Jacqueline E Villalta, Leanne Jg Chan, Samir Kharbanda, Jonathon J O'Brien, Fiona E McAllister, Ari J Firestone, Calvin H Jan, Jeffrey Settleman
Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance. eLife 8 (2019)
Jeffrey Settleman, Charles L Sawyers, Tony Hunter
Challenges in validating candidate therapeutic targets in cancer. eLife 7 (2018)